Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Aims While data from randomized trials suggest a declining incidence of sudden cardiac
death (SCD) among heart failure patients, the extent to which such a trend is present among …

Background: Patients with nonischemic dilated cardiomyopathy (DCM) may be at lower risk
for ventricular arrhythmias compared with those with ischemic cardiomyopathy (ICM). In …

Aims The very long-term outcome of patients who survive the first few years after receiving
cardiac resynchronization therapy (CRT) has not been well described thus far. We aimed to …

Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an
effective therapeutic strategy in patients with symptomatic heart failure with a reduced left …

Background It remains to be determined whether patients receiving cardiac
resynchronization therapy (CRT) benefit from the addition of an implantable cardioverter …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Background Primary prevention of sudden cardiac death by means of implantable
cardioverter‐defibrillators constitutes the holy grail of arrhythmology. However, current risk …

Objective Among primary prevention patients with heart failure receiving cardiac
resynchronisation therapy (CRT), the impact of additional implantable cardioverter …

Background Trends of de novo implantation of cardiac implantable electronic devices
(CIEDs) including implantable cardioverter‐defibrillator (ICD) and cardiac resynchronization …